title: High-dose interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma: still the standard.
authors.affiliation: St. Luke's-Roosevelt Hospital Center, Continuum Cancer Centers, New York, New York, USA.
authors.forename: Janice P
authors.initials: JP
authors.lastname: Dutcher
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D002986:Clinical Trials as Topic; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2